Mark Coleman, Director of Axsome Therapeutics AXSM, has filed 3 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $8.2M. The latest trade was on 06/10.

MC

MC

Mark Coleman

Director

Company

Axsome Therapeutics AXSM

First filing

23/01/04

Trades

37 trades

Buys / sales

3 / 12

12-month net buying

−$8.2M

Last trade

06/10

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Axsome TherapeuticsAXSM	Open-market sale10b5-1 plan	06/10	06/10	643 sh	$249.00	$160,107	−2.1%
Axsome TherapeuticsAXSM	Open-market sale10b5-1 plan	05/29–06/02	06/02	17,537 sh3 trades	$229.20avg.	$4,019,470.43	−37.2%
Axsome TherapeuticsAXSM	Open-market sale10b5-1 plan	02/26	02/27	25,000 sh	$161.11	$4,027,750	−34.7%
Axsome TherapeuticsAXSM	Open-market buy	25/09/08	25/09/09	1,575 sh3 trades	$127.28avg.	$200,466.3	+3.4%
Axsome TherapeuticsAXSM	Open-market sale10b5-1 plan	25/05/27–25/05/28	25/05/29	7,500 sh2 trades	$104.45avg.	$783,375	−13.9%
Axsome TherapeuticsAXSM	Open-market sale	25/05/20	25/05/20	3,000 sh	$107.49	$322,470	−5.3%
Axsome TherapeuticsAXSM	Open-market sale10b5-1 plan	24/05/28–24/05/29	24/05/29	10,497 sh2 trades	$75.18avg.	$789,112.01	−41.8%
Axsome TherapeuticsAXSM	Open-market sale10b5-1 plan	23/09/15	23/09/15	29,588 sh2 trades	$75.18avg.	$2,224,536	No record